image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 21.93
-1.17 %
$ 3.73 B
Market Cap
18.43
P/E
1. INTRINSIC VALUE

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.[ Read More ]

The intrinsic value of one OPCH stock under the base case scenario is HIDDEN Compared to the current market price of 21.9 USD, Option Care Health, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart OPCH

image
FINANCIALS
4.3 B REVENUE
9.06%
315 M OPERATING INCOME
30.96%
267 M NET INCOME
77.40%
371 M OPERATING CASH FLOW
38.78%
-56.5 M INVESTING CASH FLOW
47.70%
-265 M FINANCING CASH FLOW
-1736.48%
1.28 B REVENUE
4.19%
85.1 M OPERATING INCOME
5.47%
53.9 M NET INCOME
1.53%
160 M OPERATING CASH FLOW
-18.02%
-9.67 M INVESTING CASH FLOW
1.10%
-44.6 M FINANCING CASH FLOW
-56.30%
Balance Sheet Decomposition Option Care Health, Inc.
image
Current Assets 1.09 B
Cash & Short-Term Investments 344 M
Receivables 378 M
Other Current Assets 373 M
Non-Current Assets 2.12 B
Long-Term Investments 31.1 M
PP&E 205 M
Other Non-Current Assets 1.89 B
Current Liabilities 618 M
Accounts Payable 427 M
Short-Term Debt 42.6 M
Other Current Liabilities 149 M
Non-Current Liabilities 1.18 B
Long-Term Debt 1.14 B
Other Non-Current Liabilities 34.9 M
EFFICIENCY
Earnings Waterfall Option Care Health, Inc.
image
Revenue 4.3 B
Cost Of Revenue 3.32 B
Gross Profit 981 M
Operating Expenses 667 M
Operating Income 315 M
Other Expenses 47.5 M
Net Income 267 M
RATIOS
22.81% GROSS MARGIN
22.81%
7.31% OPERATING MARGIN
7.31%
6.21% NET MARGIN
6.21%
18.79% ROE
18.79%
8.30% ROA
8.30%
9.36% ROIC
9.36%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Option Care Health, Inc.
image
Net Income 267 M
Depreciation & Amortization 62.2 M
Capital Expenditures -41.9 M
Stock-Based Compensation 30.5 M
Change in Working Capital -21.4 M
Others 1.83 M
Free Cash Flow 329 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Option Care Health, Inc.
image
Wall Street analysts predict an average 1-year price target for OPCH of $29.5 , with forecasts ranging from a low of $26 to a high of $36 .
OPCH Lowest Price Target Wall Street Target
26 USD 18.56%
OPCH Average Price Target Wall Street Target
29.5 USD 34.52%
OPCH Highest Price Target Wall Street Target
36 USD 64.16%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Option Care Health, Inc.
image
Sold
0-3 MONTHS
3.7 M USD 4
3-6 MONTHS
181 K USD 1
6-9 MONTHS
62.9 K USD 1
9-12 MONTHS
0 USD 0
Bought
969 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
1.1 M USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 08, 2024
Bought 969 K USD
KRAEMER HARRY M JANSEN JR
Director
+ 43000
22.5356 USD
2 months ago
Sep 03, 2024
Sell 47.4 K USD
Pate R Carter
Director
- 1465
32.3691 USD
2 months ago
Aug 22, 2024
Sell 719 K USD
SHAPIRO MICHAEL H.
Chief Financial Officer
- 23217
30.9472 USD
2 months ago
Aug 21, 2024
Sell 1.48 M USD
BETTEN ELIZABETH QUADROS
Director
- 47531
31.0856 USD
2 months ago
Aug 22, 2024
Sell 1.46 M USD
SULLIVAN TIMOTHY P
Director
- 47249
30.9126 USD
3 months ago
Aug 15, 2024
Sell 181 K USD
Bavaro Michael
Chief Human Resources Officer
- 5765
31.42 USD
8 months ago
Feb 28, 2024
Sell 62.9 K USD
Bavaro Michael
Chief Human Resources Officer
- 1984
31.7259 USD
8 months ago
Feb 26, 2024
Bought 1.1 M USD
KRAEMER HARRY M JANSEN JR
Director
+ 35000
31.5529 USD
1 year ago
Oct 30, 2023
Bought 79.1 K USD
Bierbower Elizabeth D
Director
+ 3000
26.37 USD
1 year ago
Aug 17, 2023
Bought 50.3 K USD
Pate R Carter
Director
+ 1465
34.32 USD
1 year ago
Aug 11, 2023
Bought 1.9 M USD
KRAEMER HARRY M JANSEN JR
Director
+ 55000
34.6276 USD
1 year ago
Aug 14, 2023
Bought 86.7 K USD
Smyser Collin
GC & Corporate Secretary
+ 2500
34.69 USD
1 year ago
Mar 10, 2023
Sell 193 K USD
Bavaro Michael
Chief Human Resources Officer
- 6148
31.4455 USD
1 year ago
Mar 01, 2023
Sell 469 M USD
Walgreens Boots Alliance, Inc.
10 percent owner
- 15475166
30.3 USD
2 years ago
Oct 03, 2022
Sell 61.6 K USD
Pate R Carter
Director
- 1928
31.97 USD
2 years ago
Sep 01, 2022
Sell 58.9 K USD
Pate R Carter
director:
- 1923
30.65 USD
2 years ago
Aug 16, 2022
Sell 363 M USD
WBA Investments, Inc.
director:
- 11000000
33.01 USD
2 years ago
Aug 16, 2022
Sell 363 M USD
WBA Investments, Inc.
director:
- 11000000
33.01 USD
2 years ago
Aug 01, 2022
Sell 64.2 K USD
Pate R Carter
director:
- 1923
33.37 USD
2 years ago
Jul 08, 2022
Sell 57.7 K USD
Pate R Carter
director:
- 1923
30 USD
2 years ago
Jun 06, 2022
Sell 182 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
30.25 USD
2 years ago
Jun 01, 2022
Sell 58.7 K USD
Pate R Carter
Director
- 1923
30.54 USD
2 years ago
Dec 21, 2021
Sell 138 K USD
Pate R Carter
Director
- 5125
27 USD
2 years ago
May 06, 2022
Sell 173 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
28.81 USD
2 years ago
Apr 06, 2022
Sell 163 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
27.18 USD
2 years ago
Mar 07, 2022
Sell 157 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
26.12 USD
2 years ago
Feb 07, 2022
Sell 142 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
23.61 USD
2 years ago
Jan 06, 2022
Sell 158 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
26.29 USD
3 years ago
Nov 08, 2021
Sell 168 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
27.93 USD
2 years ago
Dec 06, 2021
Sell 149 K USD
Booker Harriet
CHIEF OPERATING OFFICER
- 6000
24.81 USD
3 years ago
Sep 09, 2021
Sell 247 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 9200000
26.9 USD
3 years ago
Sep 09, 2021
Sell 247 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 9200000
26.9 USD
3 years ago
Sep 09, 2021
Sell 247 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 9200000
26.9 USD
3 years ago
Aug 17, 2021
Bought 960 K USD
KRAEMER HARRY M JANSEN JR
Director
+ 44742
21.4675 USD
3 years ago
Aug 16, 2021
Bought 113 K USD
KRAEMER HARRY M JANSEN JR
Director
+ 5258
21.4548 USD
3 years ago
Aug 05, 2021
Sell 419 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 20700000
20.25 USD
3 years ago
Aug 05, 2021
Sell 419 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 20700000
20.25 USD
3 years ago
Aug 05, 2021
Sell 419 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 20700000
20.25 USD
3 years ago
Jun 10, 2021
Sell 345 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 17250000
20 USD
3 years ago
Jun 10, 2021
Sell 345 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 17250000
20 USD
3 years ago
Jun 10, 2021
Sell 345 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 17250000
20 USD
3 years ago
May 19, 2021
Bought 704 K USD
KRAEMER HARRY M JANSEN JR
Director
+ 40000
17.5914 USD
3 years ago
May 11, 2021
Bought 164 K USD
RADEMACHER JOHN CHARLES
CHIEF EXECUTIVE OFFICER
+ 10000
16.4236 USD
3 years ago
May 10, 2021
Bought 14.3 K USD
Pate R Carter
Director
+ 855
16.7413 USD
3 years ago
May 11, 2021
Bought 40.8 K USD
SHAPIRO MICHAEL H.
CHIEF FINANCIAL OFFICER
+ 2500
16.33 USD
3 years ago
Mar 17, 2021
Sell 240 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 12000000
20 USD
3 years ago
Mar 17, 2021
Sell 240 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 12000000
20 USD
3 years ago
Mar 17, 2021
Sell 240 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 12000000
20 USD
3 years ago
Feb 10, 2021
Sell 319 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 17250000
18.5 USD
3 years ago
Feb 10, 2021
Sell 319 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 17250000
18.5 USD
3 years ago
Dec 10, 2020
Sell 319 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 17250000
18.5 USD
3 years ago
Dec 29, 2020
Sell 9 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 600000
15 USD
3 years ago
Dec 29, 2020
Sell 9 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 600000
15 USD
3 years ago
Dec 29, 2020
Sell 9 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 600000
15 USD
3 years ago
Dec 14, 2020
Sell 150 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 10000000
15 USD
3 years ago
Dec 14, 2020
Sell 150 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 10000000
15 USD
3 years ago
Dec 14, 2020
Sell 150 M USD
MADISON DEARBORN PARTNERS LLC
10 percent owner
- 10000000
15 USD
4 years ago
Aug 20, 2020
Sell 33.8 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 2700000
12.5 USD
4 years ago
Aug 20, 2020
Sell 33.8 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 2700000
12.5 USD
4 years ago
Aug 20, 2020
Sell 33.8 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 2700000
12.5 USD
4 years ago
Jul 24, 2020
Sell 100 M USD
SULLIVAN TIMOTHY P
director, 10 percent owner:
- 8000000
12.5 USD
4 years ago
Jul 24, 2020
Sell 100 M USD
BETTEN ELIZABETH QUADROS
director, 10 percent owner:
- 8000000
12.5 USD
4 years ago
Jul 24, 2020
Sell 100 M USD
MADISON DEARBORN PARTNERS LLC
director, 10 percent owner:
- 8000000
12.5 USD
4 years ago
May 11, 2020
Bought 25.1 K USD
NIELSEN ALAN TROY
Director
+ 2000
12.5451 USD
7 years ago
Nov 09, 2017
Bought 20.3 K USD
Deitsch Stephen
Chief Financial Officer
+ 10000
2.03 USD
7 years ago
Nov 09, 2017
Bought 30.5 K USD
GREENLEAF DANIEL E
Chief Executive Officer
+ 15000
2.033 USD
7 years ago
Sep 15, 2017
Sell 72.7 K USD
Bronfein Michael G
Director
- 27000
2.6938 USD
7 years ago
Sep 05, 2017
Sell 683 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 221829
3.08 USD
7 years ago
Sep 06, 2017
Sell 3.99 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 1349475
2.96 USD
7 years ago
Sep 07, 2017
Sell 3.67 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 1275637
2.88 USD
7 years ago
Aug 15, 2017
Sell 681 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 216300
3.15 USD
7 years ago
Aug 16, 2017
Sell 360 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 115702
3.11 USD
7 years ago
Aug 17, 2017
Sell 1.69 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
- 554476
3.05 USD
8 years ago
Nov 11, 2016
Bought 13.2 K USD
Kreger Jeffrey M
Chief Financial Officer
+ 10000
1.32 USD
8 years ago
Nov 10, 2016
Bought 20.8 K USD
GREENLEAF DANIEL E
Chief Executive Officer
+ 16000
1.299 USD
8 years ago
Nov 10, 2016
Bought 26 K USD
Pate R Carter
Director
+ 20000
1.3 USD
8 years ago
Jun 22, 2016
Bought 8.4 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 4200000
2 USD
8 years ago
Jun 17, 2016
Bought 200 K USD
Bronfein Michael G
Director
+ 80000
2.4966 USD
8 years ago
Jun 17, 2016
Bought 62.2 K USD
GOLDSTEIN MICHAEL
Director
+ 25000
2.4878 USD
8 years ago
Jun 17, 2016
Bought 62.4 K USD
Pate R Carter
Director
+ 25000
2.4963 USD
8 years ago
Jun 17, 2016
Bought 31 K USD
GOLDING DAVID W
Director
+ 12500
2.4782 USD
9 years ago
Aug 24, 2015
Bought 1.48 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 789503
1.88 USD
9 years ago
Aug 21, 2015
Bought 724 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 397900
1.82 USD
9 years ago
Aug 21, 2015
Bought 724 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 397900
1.82 USD
9 years ago
Aug 20, 2015
Bought 418 K USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 235007
1.78 USD
9 years ago
Aug 18, 2015
Bought 30.8 K USD
GOLDING DAVID W
Director
+ 20000
1.541 USD
9 years ago
May 19, 2015
Bought 40.2 K USD
GOLDING DAVID W
Director
+ 10000
4.0159 USD
9 years ago
Mar 16, 2015
Bought 21.3 K USD
SMITH RICHARD M
President and CEO
+ 5000
4.27 USD
9 years ago
Mar 12, 2015
Bought 17.4 K USD
JORDEN YON
Director
+ 5000
3.47 USD
9 years ago
Mar 09, 2015
Bought 9.53 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 1800000
5.295 USD
9 years ago
Mar 09, 2015
Bought 11.9 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 1800000
6.595 USD
9 years ago
Mar 09, 2015
Bought 3.23 M USD
Coliseum Capital Management, LLC
director, 10 percent owner:
+ 625000
5.17 USD
10 years ago
Jun 16, 2014
Sell 39.7 K USD
HOLUBIAK MYRON Z
Director
- 5000
7.9401 USD
10 years ago
May 14, 2014
Bought 36.1 K USD
JORDEN YON
Director
+ 5000
7.214 USD
7. News
Option Care Health, Inc. (OPCH) Q3 2024 Earnings Call Transcript Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President-Finance John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants David MacDonald – Truist Constantine Davides – Citizens JMP Securities Lisa Gill – JPMorgan Matt Larew – William Blair Brian Tanquilut – Jefferies Jamie Perse – Goldman Sachs Pito Chickering – Deutsche Bank Joanna Gajuk – Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 2 weeks ago
Option Care (OPCH) Surpasses Q3 Earnings and Revenue Estimates Option Care (OPCH) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.31 per share a year ago. zacks.com - 2 weeks ago
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2024 BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. globenewswire.com - 2 weeks ago
Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. globenewswire.com - 1 month ago
OPCH vs. ASTH: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Astrana Health, Inc. (ASTH). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 3 months ago
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know The average of price targets set by Wall Street analysts indicates a potential upside of 31.8% in Option Care (OPCH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com - 3 months ago
Should Value Investors Buy Option Care Health (OPCH) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 3 months ago
Option Care Health, Inc. (OPCH) Q2 2024 Earnings Call Transcript Option Care Health, Inc. (NASDAQ:OPCH ) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Nicole Maggio - Senior Vice President of Finance John Rademacher - President & CEO Mike Shapiro - CFO Conference Call Participants Lisa Gill - JPMorgan Constantine Davides - Citizens JMP Matt Larew - William Blair David MacDonald - Truist Securities Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Michael Petusky - Barrington Research Operator Good day, and thank you for standing by. Welcome to the Option Care Health Second Quarter 2024 Earnings Conference Call. seekingalpha.com - 3 months ago
Option Care (OPCH) Q2 Earnings and Revenues Top Estimates Option Care (OPCH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.63 per share a year ago. zacks.com - 3 months ago
Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024 BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. globenewswire.com - 3 months ago
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. globenewswire.com - 4 months ago
The 3 Highest-Rated Medical Stocks You Can Buy Today The medical field is a non-negotiable aspect of society. Advanced healthcare is required to combat existing diseases and protect ourselves from new ones. investorplace.com - 4 months ago
8. Profile Summary

Option Care Health, Inc. OPCH

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 3.73 B
Dividend Yield 0.00%
Description Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Contact 3000 Lakeside Drive, Bannockburn, IL, 60015 https://www.optioncarehealth.com
IPO Date Aug. 15, 1996
Employees 7500
Officers Mr. Collin G. Smyser General Counsel & Corporate Secretary Ms. Caroline Budde Senior Vice President & Chief Compliance Officer Mr. Chris Grashoff Chief Growth Officer Mr. Brett Michalak Chief Information Officer Mr. Michael Bavaro Chief Human Resources & Chief Diversity Officer Mr. Michael H. Shapiro Executive Vice President & Chief Financial Officer Ms. Julie Koenig Senior Vice President of Operations Mr. Luke Whitworth Chief Operating Officer Mr. John C. Rademacher Chief Executive Officer, President & Director Ms. Nicole Maggio Principal Accounting Officer